Eslicarbazepine acetate ( BIA 2-093 , S- ( - ) -10-acetoxy-10,11-dihydro-5H-dibenzo/b , f/azepine-5-carboxamide ) is a novel antiepileptic drug , now in Phase III clinical trials , designed with the aim of improving efficacy and safety in comparison with the structurally related drugs carbamazepine ( CBZ ) and oxcarbazepine ( OXC ) .
B-ChemicalEntity I-ChemicalEntity O B-ChemicalEntity I-ChemicalEntity O B-ChemicalEntity I-ChemicalEntity I-ChemicalEntity I-ChemicalEntity I-ChemicalEntity I-ChemicalEntity I-ChemicalEntity O O O O B-ChemicalEntity I-ChemicalEntity O O O O O O O O O O O O O O O O O O O O O O O O B-ChemicalEntity O B-ChemicalEntity O O B-ChemicalEntity O B-ChemicalEntity O O